Walleye Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,400
Closed -$62.1K 4389
2025
Q3
$62.1K Buy
+2,400
New +$55.6K ﹤0.01% 3893
2024
Q1
Sell
-11,600
Closed -$460K 4826
2023
Q4
$460K Buy
11,600
+10,600
+1,060% +$312K ﹤0.01% 3153
2023
Q3
$27.5K Sell
1,000
-600
-38% -$18.8K ﹤0.01% 4335
2023
Q2
$54.3K Buy
+1,600
New +$53.9K ﹤0.01% 3938
2023
Q1
Sell
-2,700
Closed -$120K 4893
2022
Q4
$120K Buy
2,700
+1,100
+69% +$39.3K ﹤0.01% 3876
2022
Q3
$45K Sell
1,600
-7,300
-82% -$224K ﹤0.01% 4264
2022
Q2
$240K Sell
8,900
-17,800
-67% -$517K ﹤0.01% 3553
2022
Q1
$909K Buy
+26,700
New +$854K ﹤0.01% 2310
2021
Q4
Sell
-11,400
Closed -$615K 5402
2021
Q3
$615K Buy
+11,400
New +$535K ﹤0.01% 2727
2020
Q3
Sell
-5,000
Closed -$65K 4163
2020
Q2
$65K Buy
+5,000
New +$22.2K ﹤0.01% 3712

Other funds holding CLDX